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Abstract
Background: The Mood Disorder Questionnaire (MDQ) is a well-recognized screening tool for bipolar disorder, but
its Chinese version needs further validation. This study aims to measure the accuracy of the Chinese version of the
MDQ as a screening instrument for bipolar disorder (BPD) in a group of patients with a current major depressive
episode.
Methods: 142 consecutive patients with an initial DSM-IV-TR diagnosis of a major depressive episode were
screened for BPD using the Chinese translation of the MDQ and followed up for one year. The final diagnosis,
determined by a special committee consisting of three trained senior psychiatrists, was used as a ‘gold standard’
and ROC was plotted to evaluate the performance of the MDQ. The optimal cut-off was chosen by maximizing the
Younden’s index.
Results: Of the 142 patients, 122 (85.9%) finished the one year follow-up. On the basis of a semi-structured clinical
interview 48.4% (59/122) received a diagnosis of unipolar depression (UPD), 36.9% (45/122) BPDII and 14.8% (18/
122) BPDI. At the end of the one year follow-up,9 moved from UPD to BPD, 2 from BPDII to UPD, 1 from BPDII to
BPDI, the overall rate of initial misdiagnosis was 16.4%. MDQ showed a good accuracy for BPD: the optimal cut-off
was 4, with a sensitivity of 0.72 and a specificity of 0.73. When BPDII and BPDI were calculated independently, the
optimal cut-off for BPDII was 4, with a sensitivity of 0.70 and a specificity of 0.73; while the optimal cut-off for BPDI
was 5, with a sensitivity of 0.67 and a specificity of 0.86.
Conclusions: Our results show that the Chinese version of MDQ is a valid tool for screening BPD in a group of
patients with current depressive episode on the Chinese mainland.
Background
Many studies have reported that patients with BPD are
frequently misdiagnosed with other disorders. The fre-
quency of initial misdiagnosis was reported to be as
high as 69%, with more than one third of patients with
BPD incorrectly diagnosed for up to ten years or longer
[1]. At the same time, over-diagnosis of BPD is also
reported to be common. Previous studies [2,3] showed
that the frequency of over-diagnosis could be more than
50%. Inaccurate and delayed diagnosis can often lead to
inappropriate treatment, which in turn results in poor
outcome [4].
A number of strategies have been proposed to
improve the detection of BPD in clinical practice. Using
the Mood Disorder Questionnaire (MDQ) [5] is one of
the common strategies. MDQ has been translated into
many languages and has been proved to be a helpful
tool in screening BPD [6-9]. A Chinese version of MDQ
(Additional file 1: Chinese version of Mood Disorder
Questionnaire) is a useful screening tool for BPD in a
psychiatric population but not in the general population
in Hong Kong [9,10]. However, the psychometric
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provided the original work is properly cited.properties of MDQ were found to differ slightly under
different language settings and among different popula-
tions [6-9].
The MDQ’s poor performance in identifying mild
bipolar spectrum, such as BPDII [11], greatly reduces its
value, since BPDII accounts for the majority of misdiag-
nosis among patients with BPD in clinical practice
[1,12]. Section 2 and 3 of MDQ might partly contribute
to this problem [11,13,14]. Another potential reason
might be the gold standard used as a reference. Over
the past decades, most studies used a single structural
clinical interview as a gold standard for diagnostic eva-
luation. However, a number of studies have shown that
as i n g l es t r u c t u r a lc l i n i c a li n t e r v i e wb a s e do nD S M - I V
criteria is far from enough to achieve an accurate diag-
nosis of BPD in clinical practice, especially for those
with BPDII [15]. For instance, according to the variation
of observation length, approximate 12.5%-30% patients
with an initial diagnosis of UPD eventually received a
diagnosis of BPD [16-18].
In the present study, we hypothesized that, among
patients with current depressive episode, it might be rea-
sonable and valuable to use MDQ as a screening tool for
BPD, since most of those patients with bipolar spectrum
disorder, especially BPDII, visit doctors when they are
depressed, which makes them more likely to be misdiag-
nosed as UPD [17]. We decided to follow up patients for
one year to evaluate the initial diagnosis based on a SCID-
I interview in an attempt to improve the accuracy of the
gold standard. Finally, the performance of MDQ without
section 2 and 3 was also assessed.
Methods
Subjects
This study sample consisted of 142 eligible subjects that
were treated currently for major depressive episode
(MDE) based on the criteria of DSM-IV-TR in the psy-
chiatric department, the 3
rd Affiliated Hospital of Sun
Yat-sen University between July 2006 and July 2007.
Written informed consent was obtained from all partici-
pants, and all procedures used in the present study were
reviewed and approved by the local institutional review
board. Patients with a psychiatric or physical disorder
that prevented them from being interviewed or under-
mined their ability to provide accurate information, and
those who declined participation in the study or refused
to provide informed consent were excluded.
Instruments
The Chinese version of SCID-I [19]: Chinese version of
the Structured Clinical Interview for the Diagnostic and
S t a t i s t i c a lM a n u a lo fM e n t a lD isorders, Fourth Edition,
Text Revision (DSM-IV-TR) Axis 1 Disorders (SCID-I)
was used for diagnostic interview.
MDQ [5]: The translation of MDQ into Chinese was
approved by one of the developers of the original version.
The Chinese version was translated back into English and
re-edited to make it comparable to the original version.
Procedure
Prior to the start of this study, three senior psychiatrists
(HZL, GNH and WXL) attended a training program
focused on SCID-I. At the end of the program, their inter-
rater reliability was high, with a kappa coefficient of 0.93.
Throughout the study period, all diagnostic interview and
assessments were performed by these three psychiatrists,
who constituted a special committee responsible for these
tasks and were blind to the result of the MDQ.
Potential participants for this study were found by a
study nurse (LKL) through reviewing the archive records
and clinical outpatient files. The cases were included if
they had been or would like to be followed up by the psy-
chiatrists of our department. At the study entry, partici-
pants were invited (by LKL) to fill in the Chinese version
of MDQ. SCID-I was performed for each participant to
establish an initial diagnosis meeting the criteria of DSM-
IV-TR. Demographic and clinical characteristics and fea-
tures of the current depressive episode were collected
using the self-compiled questionnaire. The participants
were then followed up for one year, being interviewed by
one of the three senior psychiatrists for at least six times
with a flexible interval of 1-2 months via telephone or face
to face. At each interview, if suspected diagnostic change
was detected, the patient’s relatives or friends were asked
to provide additional information and the patient was
asked whether they had similar experience before. All the
data about the patient was then submitted to the commit-
tee, who would decide whether the patient had experienced
a change in diagnosis or had experienced an earlier unrec-
ognized manic or hypomanic episode, according to the cri-
teria of DSM-IV-TR. To insure the quality and objectivity
of switch detection, those who did not complete the one
year follow-up or who were not contacted for more than 6
times within the year were excluded. At the end of study,
the committee reviewed the one year medical records and
came up with a final diagnosis.
During the study period, all treatment decisions or
c h a n g e si nt r e a t m e n tm e d i c a t i o n ss u c ha sd o s er e d u c -
tion, dose augmentation, or switch strategies were made
by their treating psychiatrists. This study was carried
out under naturalistic clinical settings and no treatment
information was obtained.
Statistical analysis
All statistical analysis was performed using commercial
statistical package SPSS 13.0(SPSS Inc., Chicago). The
Mann-Whitney U test was used to compare numerical
variables and the chi-square test was used to compare
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the internal consistency of the scale. The receiver oper-
ating characteristic (ROC) curve was plotted to assess
the screening performance of the questionnaire. Its
accuracy was calculated in terms of sensibility and speci-
ficity for each theoretically possible cut-off, and then the
method of linear interpolation was used to calculate the
sensibility and specificity for each actually possible cut-
off (number of positive answers). The optimal cut-off
was determined by maximizing the Youden’si n d e x( =
sensitivity + specificity-1).
Results
Comparison of the dropout group and the rest
At the beginning of the study, 102 subjects (71.8%) were
inpatients and 40 (28.2%) were outpatients. Of the 142
subjects, 122 (85.9%) completed the one year follow-up
receiving 6-12(7 ± 2) visits. Reasons for dropout
included transferring to another psychiatric institution
(9 subjects, 6.33%) and refusal to continue the study (11
subjects, 7.74%). No difference was found between the
dropout group and the rest with regard to demographic
and clinical features. Therefore, patients who dropped
out were excluded from subsequent analysis.
Comparison of BPD and UPD with regard to demographic
and clinical features
As Table 1 demonstrated, patients with BPD, compared
to patients with UPD, were younger, had an earlier age
onset, experienced a longer illness course and a larger
number of depressive episodes, and more likely saw
manic symptoms during a depressive episode. Patients
with BPDI differed from patients with BPDII in illness
course and the proportion of recurrent depression:
Compared to patients with UPD, the former consisted
of higher percentage of patients with recurrent depres-
sion while the latter experienced a longer illness course.
Comparison of initial diagnosis and final diagnosis
According to Table 2, both underdiagnosis and over-
diagnosis of BPD existed in this study, but the under-
diagnosis was commoner than overdiagnosis. Among
the nine patients whose diagnosis switched from UPD
to BPD, three were confirmed to have an undeclared
hypomanic episode before entry into the study by other
sources of information acquired during the follow-up
visit, diagnosis was changed in six cases because of
newly occurred manic or hypomanic episode during the
one year follow-up (all admitted they had similar
experience before). As for the two participants who
were initially diagnosed as BPD but finally moved to
UPD, they both rejected the treatment of mood stabili-
zers prescribed by their physicians because of poor tol-
erance, no switch was detected throughout the whole
follow-up period though antidepressant treatment had
been maintained. Reassessment of past data confirmed
no clinically significant hypomanic episode had hap-
pened before.
The internal consistency of the Chinese version of the
MDQ
In this sample, the Cronbach coefficient for the 13-item
symptom scale was 0.735, the item-total scale correla-
tion ranged from 0.195 (less sleep) to 0.597 (more
Table 1 The demographic and clinical features of the sample population
Features BPD
a UPD P
b
BPDI BPDII Total BPDI BPDII BPD
N = 20 N = 50 N = 70 N = 52
Age(Mean ± SD) (year) 28.0 ± 8.7 29.2 ± 8.6 28.8 ± 8.6 33.6 ± 10.5 0.023 0.009 0.007
Onset age (Mean ± SD) (year) 25.4 ± 8.2 25.7 ± 9.3 25.6 ± 8.9 31.2 ± 10.9 0.034 0.009 0.003
Duration of illness (month) 42.1 ± 34.4 51.8 ± 61.3 48.9 ± 54.6 30.8 ± 33.0 0.202 0.034 0.037
Female (%) 5(25.0) 27(54.0) 32(45.7) 29(55.8) 0.019 0.858 0.272
Atypical features
c (%) 6(30.0) 8(16.0) 14(20.0) 6(11.5) 0.060 0.513 0.212
Manic symptoms
d(%) 6(30.0) 16(32.0) 22(31.4) 4(7.7) 0.014 0.002 0.002
Comorbidity of anxiety disorder
e (%) 7(35.0) 14(28.0) 21(30.0) 16(30.8) 0.730 0.759 0.927
Comorbidity of psychoactive drug abuse (%) 1(5.0) 1(2.0) 2(2.9) 3(5.8) 0.898 0.327 0.422
Recurrent depression (%) 15(75.0) 27(54.0) 42(60.0) 23(44.2) 0.019 0.324 0.084
Number of depressive episode(c ± s) 3.6 ± 4.2 3.3 ± 4.4 3.4 ± 4.3 1.8 ± 1.0 0.006 0.015 0.009
a. The categorization was based on the final diagnosis
b. all compared with UPD
c. Atypical features including mood reactivity, overeating or weight gain, oversleeping, leaden paralysis and interpersonal rejection sensitivity
d. Manic symptoms, including speech pressure, racing thought, overconfidence, hostility, irritability, sexual interest and garish make-up were found by psychiatric
interview based on the Young Mania Rating Scale at the entry of this study
e. Anxiety disorder here consisted of generalized anxiety disorder, panic disorder, obsessive-compulsive disorder, phobia, somatization disorder
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alter the scale’s internal consistency.
Scores of MDQ in each section
Table 3 showed summary scores of all subjects in each
section of MDQ. The high proportion (34.7%) of subjects
with UPD scoring moderate or severe in section 3 and the
high prevalence of missing value in the section 2 and 3
indicated that there might be some misunderstanding in
these sections. While the percentage of those scoring
moderate or severe among subjects with BPD was less
than expected, if combined with the number of symptoms,
this percentage would be lower. Therefore, section 2 and 3
make no sense in distinguishing BPD from UPD and were
excluded from subsequent analysis.
ROC analysis of section 1
ROC was plotted according to the scores obtained in sec-
tion 1. The corresponding sensibility and specificity for
each possible cut-off (number of positive answers) were
calculated by linear interpolation based on the sensibility
and specificity of the corresponding theoretical cut-off in
ROC. The results and the corresponding area under curve
(AUC) and p value were listed in Table 4. By maximizing
the Youden’s index, 4 was selected as the optimal cut-off
for patients with BPD or BPDII, with a sensibility of 0.72
or 070 respectively and a specificity of 0.73. If BPDI was
separately calculated, 5 was considered the optimal cut-off,
with a sensibility of 0.67 and a specificity of 0.86.
Scores of section 1 among participants with diagnosis
changed during the follow-up
Compared to 50 subjects who maintained the diagnosis
of UPD, subjects whose diagnosis changed from UPD to
BPD scored significantly higher in section 1 of the
MDQ (2.7 ± 1.7 vs. 5.2 ± 3.0, p = 0.036).
Discussion and Conclusions
As this study and our previous report [20] have shown,
the diagnosis of UPD and BPD based on a single inter-
view is unstable over time, with 16.4% to 19.4% of sub-
jects changing diagnosis, similar to the range of 11.7%
to 19.7% reported in other studies [16,21,22]. Using a
diagnosis obtained at one year follow-up as ‘gold stan-
dard’ helps obtain a more reliable assessment.
Compared to the optimal cut-off of 7 reported by stu-
dies from western countries [5,7] and Hong Kong [9], this
study showed a smaller optimal cut-off, which was similar
to findings from Chinese mainland [23]. This might partly
due to the cultural differences, since Hong Kong is a very
westernized city in China, which makes its culture and
language greatly different from Chinese mainland.
In line with previous studies [5,7,8], the MDQ is more
sensitive in detecting BPDI than detecting BPDII.
Although the originator of the MDQ did not specially
access patients in remission from a mood episode, whether
the patient’s symptomatology at the time of screening will
Table 2 Comparison of initial diagnosis and final
diagnosis
Initial
diagnosis
Final diagnosis N of
cases
Percentage
(%)
UPD(59) UPD 50 84.7
BPDII 8 13.6
BPDI 1 1.6
BPDII(45) UPD 2 4.4
BPDII 42 93.3
BPDI 1 2.2
BPDI(18) UPD 0 0
BPDII 0 0
BPDI 18 100%
Total(122) Agreed with initial
diagnosis
110 83.6%
Disagreed with initial
diagnosis
12 16.4%
Table 3 Scores of the subjects in each section of MDQ
MDQ BPDI
a BPDII
a UPD
a
(N = 20) (N = 50) (N = 52)
Section 1(Number of positive answers) x ± s 6.85 ± 3.33 5.76 ± 2.73 3.02 ± 2.00**
b
Section2 Yes 12(60.0%) 26(50%) 12(23.1%)
No 6(30.0%) 16(34.6%) 30(57.7%)
Missing 2(10.0%) 8(15.4%) 10(19.2%)
Section 3 unaffected 4(21.1%) 6(12.0%) 10(19.2%)
mild 7(36.8%) 12(24.0%) 14(26.9%)
moderate 3(15.8%) 16(32.0%) 11(21.2%)
severe 3(15.8%) 13(26.0%) 7(13.5%)
missing 2(10.5%) 3(6.0%) 10(19.2%)
a. the final diagnosis after one year follow-up
b. compared to subjects with BPD, subjects with UPD scored significantly lower (P < 0.01) in section 1 of MDQ
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previous study with a small sample size [24] showed the
performance of MDQ was independent of depressive
symptoms, but the relatively low test-retest reliability
(kappa coefficient 0.64) with the whole sample implicated
the possible influence of clinically relevant factors, such as
the patient’s mood state at time of completion. While
compared to a report which sampled patients treated for
depression [15], the performance of the MDQ in detecting
B P D I Ii nt h i ss t u d yw a sq u i t ec l o s e( s e n s i b i l i t y :0 . 7 0 6v s .
0.70), in spite of the different cut-off (7 vs. 4).
According to the initial conception of the MDQ’s
developers, a subject who will be screened positive has
to meet the DSM-IV-TR criteria of manic or hypomanic
episode, including symptom criteria and severity criteria.
However, the poor performance of the section 2 and 3
in this study and other reports [6,7,15] indicates an
inadequacy in the original conception, especially when
screening patients with BPDII. In this study, we went
further by adding a question to ask subjects how long
the positive symptoms lasted. We found that 16(32%)
subjects with BPDII did not meet the DSM-IV-TR dura-
tion criteria of hypomanic episode (lasting at least 4
days). That means it is unrealistic to expect a self-rated
questionnaire to help improve recognition of a past
hypomanic episode among patients with BPDII.
However, MDQ without section 2 and 3 has been shown
to be a valid screening tool for BPDII, and even for pre-
viously unrecognized bipolar disorder [25]. One explana-
tion for this might be that MDQ without section 2 and 3
helps recognize the opposite polarity-manic or hypomanic
symptoms of BPDII, which helps improve the recognition
of BPD [26,27]. Recently, convergent evidence has shown
that bipolarity is a sensitive and characteristic feature of
BPD [26,28,29]. For instance, a cross-sectional study [30]
f o u n dt h a tc l i n i c a l l ys i g n i f i c a n td e p r e s s i v es y m p t o m s
occurred in 94.1% of those with (hypo) mania, while 70.1%
in a depressive episode had clinically significant manic
symptoms. In addition, both prospective [31] and cross-
sectional survey [32] found that major depressive disorder
(MDD) with subthreshold bipolarity shared similarities
with BPD and more likely converted into BPD during fol-
low-up. In this study, manic symptoms were also found to
be more likely to occur in patients with BPD than those
with UPD. In this context, it is not difficult to understand
why MDQ without section 2 and 3 can be used as a
screening tool to detect bipolar diathesis in depression
[28,33].
In summary, out study shows that the Chinese version
of the MDQ without section 2 and 3 is a valid, brief and
feasible tool for screening BPD from patients with a cur-
rent depressive episode in Chinese mainland, although
the psychometric properties in terms of internal consis-
tency is not as excellent as reports in western countries
[6,7], which means some modification is needed.
Furthermore, the small sample size in our study makes
a larger prospective study necessary to further testify the
validation of the Chinese version of MDQ under differ-
ent clinical settings.
Additional material
Additional file 1: Chinese version of Mood Disorder Questionnaire.
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